Deciphering interleukin 37's therapeutic potential: insights into alleviating inflammation in autosomal dominant polycystic kidney disease

Kidney Int. 2024 May;105(5):1130. doi: 10.1016/j.kint.2024.01.027.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Inflammation / drug therapy
  • Kidney
  • Polycystic Kidney, Autosomal Dominant* / complications
  • Polycystic Kidney, Autosomal Dominant* / drug therapy